Placenta Accreta, Third Trimester

2

Review clinical trials related to Placenta Accreta, Third Trimester. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Ultrasound Scoring System for Diagnosis and Prediction of Severity and Surgical Outcomes of Placenta Accreta Spectrum

Primary Objective: To determine the optimal cutoff values of the ultrasound score for different PAS subtypes (no PAS, placenta accreta, placenta increta, and placenta percreta). To evaluate the diagnostic accuracy of the novel Ultrasound Scoring System in predicting the severity of Placenta Accreta Spectrum (PAS) (placenta accreta, increta, and percreta). Secondary Objective: * To correlate the novel ultrasound score with intraoperative findings (considered the gold standard) during cesarean delivery, including the degree of placental invasion and the need for surgical interventions (hysterectomy, bladder repair). * To assess the relationship between the novel ultrasound score and postoperative complications, such as: * Requirement for hysterectomy * Bladder or bowel injury * Blood transfusion requirement * ICU admission rates * To explore the potential for integrating the Ultrasound Scoring System with other clinical indicators (e.g., patient age, parity, and history of cesarean sections) to enhance the predictive accuracy for PAS.

Participants needed: 50
Trial details
Age: 18-45Biological sex: FemaleType: ObservationalSponsor: Sohag UniversityUpdated: Aug 10, 2026
Eligibility criteria

Pregnant women aged 18 to 45 years. [+4]

Women with multiple pregnancies (twins, triplets, etc.). [+3]

Status: Not yet recruiting

Ultrasound Model to Help Differentiate Between Placenta Accreta Spectrum and Uterine Dehiscence in 3rd Trimester Pregnancies

By using 2d Ultrasound on 3rd trimester pregnant women, a model is made to help differentiate between placenta accreta spectrum and uterine scar dehiscence before operative action to help prepare multi-disciplinary steps if needed

Participants needed: 50
Trial details
Age: 18-50Biological sex: FemaleType: ObservationalSponsor: Assiut UniversityUpdated: Nov 19, 2025
Eligibility criteria

Women in 3rd trimester pregnancy with low lying placenta previa [+3]

Antepartum Hemorrhage(sever attack) as it hinders time for accurate diagnosis an...